Multivariate analysis suggested that CRP > 430 mg/dL (p = 0.021) and FGL-1 > 23.79 ng/mL (p = 0.006) were independent risk factors for IPN (Table 4). This evidence concerns the gene FGL1 and bile duct papillary neoplasm.